CDD3506

CAS No. 197913-15-8

CDD3506( 1-TRITYL-1H-IMIDAZOL-4-AMINE )

Catalog No. M26554 CAS No. 197913-15-8

CDD3506 increases high-density lipoprotein cholesterol by targeting hepatic CYP3A.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 79 Get Quote
5MG 132 Get Quote
10MG 213 Get Quote
25MG 430 Get Quote
50MG 624 Get Quote
100MG 888 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    CDD3506
  • Note
    Research use only, not for human use.
  • Brief Description
    CDD3506 increases high-density lipoprotein cholesterol by targeting hepatic CYP3A.
  • Description
    CDD3506 increases high-density lipoprotein cholesterol by targeting hepatic CYP3A.
  • In Vitro
    CDD3506 specifically induces hepatic cytochrome P450IIIA produces significant increases in HDL cholesterol.
  • In Vivo
    ——
  • Synonyms
    1-TRITYL-1H-IMIDAZOL-4-AMINE
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    P450
  • Recptor
    GPR109A| GPR109B
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    197913-15-8
  • Formula Weight
    325.415
  • Molecular Formula
    C22H19N3
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 19 mg/mL (58.39 mM)
  • SMILES
    Nc1cn(cn1)C(c1ccccc1)(c1ccccc1)c1ccccc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Jacobson MK, et al. Effect of myristyl nicotinate on retinoic acid therapy for facial photodamage. Exp Dermatol. 2007 Nov;16(11):927-35.
molnova catalog
related products
  • Isoasatone A

    Isoasatone A acts against S. litura by acting on cytochrome P450 monooxygenase and glutathione transferase. Isoasatone A is a natural product isolated from Heterotropa takaoi M..

  • (±)-N-3-Benzylnirvan...

    (±)-N-3-Benzylnirvanol is a racemic mixture of (+)-N-3-Benzylnirvanol and (-)-N-3-Benzylnirvanol. Both enantiomers are selective inhibitors of cytochrome P450, specifically inhibiting CYP2C19.

  • ε-?Viniferin

    ε-Viniferin a dimer of resveratrol, shows the inhibitory effects of epsilon-viniferin on human CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2B6, CYP2E1, CYP3A4 and CYP4A activities.